Medicamen Biotech has informed that the Board of Directors at their Meeting held on 30.6.2020 adopted the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2020. The company has enclosed the copy of the results published in the Financial Express and Jansatta dated on July 1, 2020.
The above information is a part of company’s filings submitted to BSE.